Medizone Home
×

Meet us at our booth at ARAB HEALTH 2017 – 30th Jan to 2nd Feb

We are looking forward to welcoming you at our booth at ARAB HEALTH - Stand No. Z3.E39 in the "German Hall". 30th January to 2nd February 2017. For more information visit ARAB HEALTH exhibitor ...

FDA approves first biosimilar Zarxio (filgrastim-sndz) from Sandoz

Sandoz, a Novartis company, announced that the US Food and Drug Administration (FDA) approved Zarxio (filgrastim-sndz) for all indications included in the reference product’s label. Sandoz is the first ...

Samsung Bioepis submits Enbrel biosimilar to EMA

Samsung Bioepis Co., Ltd., announced that the Marketing Authorization Application (MAA) for its Enbrel (etanercept) biosimilar candidate, SB4 has been validated and accepted for review by European Medicines ...

Consensus Document On Biosimilar Medicines Paper Is Now Available In Five Languages

Brussels, 25 June 2014 - After its successful launch in May 2013, the European Consensus Information Paper What you need to know about Biosimilar Medicinal Products is now available in English, French, German, ...
Pages:«123